US Stock MarketDetailed Quotes

KALV KalVista Pharmaceuticals

Watchlist
  • 10.780
  • +0.290+2.76%
Close Apr 26 16:00 ET
  • 10.780
  • 0.0000.00%
Post 16:20 ET
454.79MMarket Cap-3455P/E (TTM)

KalVista Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

KalVista Pharmaceuticals Earnings Date

Currency: USD

Period

Q3 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.84

-12.00%
Analyst Rating

Strong Buy

Apr 28, 2024

KalVista Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--

Unlock Free Earnings Estimates

KalVista Pharmaceuticals Earnings Reports

  • KalVista Pharmaceuticals | 10-Q: Quarterly report

    Mar 11 16:28 ET

  • KalVista Pharmaceuticals: Q2 2024 Earnings Report

    Dec 7, 2023 16:07 ET

  • KalVista Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    Sep 7, 2023 16:18 ET

  • KalVista Pharmaceuticals | 10-K: FY2023 Annual Report

    Jul 7, 2023 18:55 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 28, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg